Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Triclocarbon Category I Antibacterial Efficacy Supported By Bayer Studies

This article was originally published in The Tan Sheet

Executive Summary

Triclocarbon in concentrations up to 1.5% should be included as a Category I active ingredient in the healthcare antiseptic tentative final monograph, Bayer advises FDA in a 1Dec. 28 citizen petition

You may also be interested in...



Triclosan Antiseptic Category I Status Requested By CIBA

FDA should consider new safety data supporting Category I (safe and effective) status for triclosan in the OTC Tentative Final Monograph for Health Care Antiseptic Drug Products, CIBA Specialty Chemicals and an alliance of six triclosan manufacturers/marketers state in a Sept. 13 citizen petition.

Health-Care Antiseptics OTC Labeling Amendments Proposed By CTFA/SDA

Labeling of antibacterial consumer hand and body products should include a "qualified" warning statement regarding children's use of such items, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association suggest in a citizen petition filed with FDA April 2.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel